Targeting MDSC expression of CCR2 led to the downregulation of other chemokine receptors in MDSC, such as CCR1, CCR5 and CXCR4, supporting the pivotal role of CCR2-CCL2 signaling in in vivo MDSC migration and tumor growth [25]. The gene discussed is CXCR4; the disease is neoplasm.